[1] |
American College of Obstetricians and Gynecologists′ Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins—Obstetrics.ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease[J].Obstet Gynecol,2019,133(5):e320-e356.
|
[2] |
Silversides CK, Harris L, Haberer K,et al. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes[J]. Am J Cardiol, 2006,97(8): 1206-1212.
|
[3] |
Goland S, van Hagen IM, Elbaz-Greener G,et al. Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC)[J].Eur Heart J,2017,38(35):2683-2690.
|
[4] |
Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J].J Am Coll Cardiol, 2020,76(25):e159-e240.
|
[5] |
Lin J, Qian Y, Chen Q, et al. The burden of premature ventricular contractions predicts adverse fetal and neonatal outcomes among pregnant women without structural heart disease: A prospective cohort study[J].Clin Cardiol, 2021, 44(6): 833-838.
|
[6] |
马玉燕,卢瑞慧.妊娠合并室性心律失常的管理[J].中国实用妇科与产科杂志,2019,35(11):1196-1200.
|
[7] |
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J,et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy[J].Eur Heart J, 2018, 39(34): 3165-3241.
|
[8] |
deSouza IS, Martindale JL, Sinert R. Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review[J].Emerg Med J,2015, 32(2): 161-167.
|
[9] |
Al-Khatib SM, Stevenson WG, Ackerman MJ, et al.2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology[J].Heart Rhythm,2018,15(10): e190-e252.
|
[10] |
Otto CM. Heartbeat: When should patients consider implantable cardiac defibrillator deactivation?[J].Heart, 2020,106(3):165-167.
|
[11] |
Bateman BT, Heide-Jørgensen U, Einarsdóttir K, et al. β-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study[J].Ann Intern Med, 2018, 169(10): 665-673.
|
[12] |
中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会.2020室性心律失常中国专家共识(2016共识升级版)[J].中华心律失常学杂志,2020,24(3): 188-258.
|
[13] |
Offerhaus JA, Bezzina CR, Wilde AAM. Epidemiology of inherited arrhythmias[J]. Nat Rev Cardiol, 2020,17(4): 205-215.
|
[14] |
林建华,张卫社,张军,等. 妊娠合并心脏病的诊治专家共识(2016)[J]. 中华妇产科杂志,2016,51(6):401-409.
|
[15] |
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy[J]. Eur Heart J,2018,39(34):3165-241.
|
[16] |
葛静,单莉莉,安娜,等.妊娠合并心脏病剖宫产患者围手术期容量管理相关研究[J]. 中国实用妇科与产科杂志,2020,36(2):159-162.
|
[17] |
Kugamoorthy P, Spears DA. Management of tachyarrhythmias in pregnancy-A review[J]. Obstet Med, 2020,13(4): 159-173.
|
[18] |
Garg L, Garg J, Krishnamoorthy P, et al. Influence of Pregnancy in Patients With Congenital Long QT Syndrome[J]. Cardiol Rev, 2017, 25(4): 197-201.
|